DNAAF1

Chr 16AR

dynein axonemal assembly factor 1

Also known as: CILD13, DAU1, LRRC50, ODA7, swt

The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.001 OMIM phenotype
Clinical SummaryDNAAF1
🧬
Gene-Disease Validity (ClinGen)
primary ciliary dyskinesia 13 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
67 unique Pathogenic / Likely Pathogenic· 335 VUS of 766 total submissions
📖
GeneReview available — DNAAF1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.00LOEUF
pLI 0.000
Z-score 1.56
OE 0.70 (0.501.00)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-1.99Z-score
OE missense 1.28 (1.191.38)
502 obs / 391.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.70 (0.501.00)
00.351.4
Missense OE?1.28 (1.191.38)
00.61.4
Synonymous OE?1.17
01.21.6
LoF obs/exp: 22 / 31.4Missense obs/exp: 502 / 391.4Syn Z: -1.74

This gene — mechanism propensity

DN
0.7035th %ile
GOF
0.77top 25%
LOF
0.2679th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

766 submitted variants in ClinVar

Classification Summary

Pathogenic50
Likely Pathogenic17
VUS335
Likely Benign227
Benign78
Conflicting50
50
Pathogenic
17
Likely Pathogenic
335
VUS
227
Likely Benign
78
Benign
50
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
41
1
8
0
50
Likely Pathogenic
16
1
0
0
17
VUS
6
310
17
2
335
Likely Benign
0
23
66
138
227
Benign
0
13
60
5
78
Conflicting
50
Total63348151145757

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

45 pathogenic / likely-pathogenic (of 78) ClinVar copy-number / structural variants overlap DNAAF1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

DNAAF1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →